Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209,298 | 79,022 | 203,397 | N/A | 0 |
| Marketable Securities | 157,742 | 116,371 | N/A | N/A | 0 |
| TOTAL | $368,370 | $196,530 | $204,193 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,275 | 1,612 | 1,200 | N/A | 0 |
| Other Non-Current Assets | 108 | 190 | 211 | 0 | 0 |
| TOTAL | $2,383 | $1,802 | $1,411 | $N/A | $0 |
| Total Assets | $370,753 | $198,332 | $205,604 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,320 | 1,004 | 2,751 | 0 | 0 |
| Accrued Expenses | 4,405 | 1,505 | 1,297 | N/A | 0 |
| Other current liabilities | N/A | 1,079 | 817 | N/A | 0 |
| TOTAL | $6,725 | $3,588 | $4,865 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,439 | 1,480 | 1,747 | 0 | 0 |
| TOTAL | $1,439 | $1,573 | $1,822 | $N/A | $0 |
| Total Liabilities | $8,164 | $5,160 | $6,687 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,521 | 38,349 | 38,314 | N/A | 36,867 |
| Common Shares | 42 | 38 | 38 | N/A | 0 |
| Retained earnings | -58,004 | -44,986 | -35,934 | N/A | 0 |
| Other shareholders' equity | -297 | -107 | 0 | 0 | 0 |
| TOTAL | $362,589 | $193,172 | $198,917 | $N/A | $0 |
| Total Liabilities And Equity | $370,753 | $198,332 | $205,604 | $0 | $0 |